The UAE flu diagnostic and treatment market is projected to grow at a CAGR of 8.76% throughout the forecast period to reach a market size of US$185.051 million by 2027. The market was valued at US$102.775 million in 2020.
The market in the United Arab Emirates is poised to grow at a slow CAGR throughout the forecast period, as the market growth in the country is primarily based on the seasonal outbreak of flu throughout the country only. Furthermore, the high purchasing power of the people, coupled with the presence of a world-class healthcare system in the country, is also one of the factors that are expected to collectively contribute to the market growth in the UAE during the next five years.
The country’s healthcare is regulated at the federal and emirate levels. Furthermore, the continuously developing private healthcare sector of the country is also projected to propel the growth opportunities for the market to surge throughout the forecast period and beyond.
In addition, the availability of a well-established public healthcare system that is majorly government-funded with the aim of delivering high-quality health services and treatments to the population of the country is also anticipated to positively impact the United Arab Emirates flu diagnostic and treatment market growth during the coming years. Furthermore, the high incidence of seasonal flu in the country is also leading to significant market growth throughout the forecast period and beyond.
The UAE’s flu diagnostic and treatment market has been segmented on the basis of the type of flu, offering, age group, and end-user. Based on the type of flu, the market has been classified into type A and type B. By type of flu, type A is projected to hold a notable market share due to the high number of diagnosed cases with type A influenza virus. However, type B flu is anticipated to surge at a significant rate due to the rising prevalence of flu cases with type B flu.
The market has been divided into three age groups: 0-14 years, 15-64 years, and >=65 years. By offering, the market has been segmented into diagnostics and therapeutics. Based on the age group, the 15-64 age group segment is projected to show decent growth over the next five years.
By the end-user, the segmentation has been done based on the hospital laboratory, outpatient clinic, and reference laboratory. The hospital laboratory segment is anticipated to hold a noteworthy market share on account of the presence of well-established facilities throughout the country, coupled with the high purchasing power of the people, which is also supporting the growth of this segment.
UAE Flu Diagnostic and Treatment Market Segmentation: